Updated 08:04 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,875.30 +0.58% CL 85.14 -0.68% BTC 64,609.30 -0.38%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,875 +0.58% BTC $64,609 −0.38% VIX 22.91 +18.70% latest tape · as of 08:04 UTC
The Screen

Caledonia Investments Ord

CLDN.L · LSE · GBp · Market cap $197.0B

Not yet scored
404.00 GBp

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 08:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price404.00 GBp at the 13 Nov 2026 close
  • Fair value420.00. Our model only; only one analyst covers it, too few to cross-check it.
  • Our value readFair vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenNot yet scored
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: range not available, base estimate 420.00 GBp (screen dated 2026-11-13).

Current read
Markup ?
Fair · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical screen not yet scored
Price404.00 GBp
Fair value420.00Our model only; only one analyst covers it, too few to cross-check it.
Ethical score70.0/100
Value readFairas of 13 Nov 2026
Our investment reviews on this name
2026-11-15Read Markup404.00+0.0% to today ✓Markdown gives way to Markup after a 5% rise in 6 weeks
2026-10-02Read Markdown383.50+5.3% to today Accumulation gives way to Markdown after an 8% rise in 5 weeks
2026-08-25Read Accumulation355.50+13.6% to today ✓Markup gives way to Accumulation
2026-07-02Read Markup355.50+13.6% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Caledonia Investments Ord holds its Markup at $404.00. The statistical read favours the sellers, held for 260 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 260 days
Price at the screen$404.00
Valuation13.67 trailing · N/A forward price to earnings
Values screenNot scored · score 70.0
The Workings

Five Screens, Shown in Full

This security has not been fully scored against the values screen yet.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 3.29% Below 49% Money owed to the company is 3.3% of assets, under the 49% limit. Pass
Revenue purity 3.36% Below 5% Only 3.4% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

The Read, in Plain English

We do not yet have the financial statements needed to run the debt, cash, receivables and income screens for Caledonia Investments Ord, so it is not scored yet.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

What the Numbers Say It Is Worth

The Fair Value Range

Our model only; only one analyst covers it, too few to cross-check it.

Our analysis reads Fair vs our fair value, as of 13 Nov 2026: it trades at roughly a 4% discount to our 420.00 GBp fair value.

How a fair value is estimated: discounted cash flow (DCF).

420.00Conservative420.00Base case420.00Growth case 404.00Price

Fair value range in GBp, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 3.8% discount to the base estimate.

Reading the gap · Our model sees value the Street hasn't fully caught up to yet.

Projections

Where our models see it going: fair-value estimate 420.00 GBp, range not available, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it is worth knowing

A quality business. It trades close to our 420.00 GBp fair value, so the easy discount is gone; you would be paying up for the quality.

The fundamentals · plain-English read
Trailing P/E13.7xreasonably valued
Dividend yield2.11%
52-week range3.56 - 592.46
Market cap$197.0B

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CLDN.L trades on LSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Markup · changed $404.00 +5.5% Entry 10

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-11-08 Markdown $383.00 -0.1% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-10-28 Markdown $383.50 +0.0% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-10-15 Markdown $383.50 +0.0% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-10-02 Markdown · changed $383.50 +7.9% Entry 6

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-08-25 Accumulation · changed $355.50 +0.0% Entry 5

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-07-24 Markup $355.50 +0.0% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-07-18 Markup $355.50 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 9307%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (1 analysts) rates it none, with a mean price target of $420.

2026-07-03 Markup $355.50 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Markup $355.50 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $365.00 -4.4% · $956 -4.4%
2 months $339.00 +3.0% · $1,030 +3.0%
3 months $334.00 +4.5% · $1,045 +4.5%
6 months $386.00 -9.6% · $904 -9.6%
1 year $3.71 +9,306.6% $9.07 $96,511 +9,551.1%
2 years $3.37 +10,258.8% $16.19 $108,393 +10,739.3%
3 years $3.25 +10,626.2% $23.00 $114,331 +11,333.1%
5 years $2.74 +12,648.6% $53.39 $146,988 +14,598.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CLDN.L does next, these words stay.

Caledonia Investments Ord · CLDN.L · Markup · $404.00
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.